NO20000202L - Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid - Google Patents
Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkaridInfo
- Publication number
- NO20000202L NO20000202L NO20000202A NO20000202A NO20000202L NO 20000202 L NO20000202 L NO 20000202L NO 20000202 A NO20000202 A NO 20000202A NO 20000202 A NO20000202 A NO 20000202A NO 20000202 L NO20000202 L NO 20000202L
- Authority
- NO
- Norway
- Prior art keywords
- group
- immunogenic conjugates
- influenzae polysaccharide
- meningococcal porin
- porin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5295297P | 1997-07-17 | 1997-07-17 | |
| US5779597P | 1997-09-08 | 1997-09-08 | |
| PCT/US1998/014838 WO1999003501A1 (en) | 1997-07-17 | 1998-07-17 | Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000202D0 NO20000202D0 (no) | 2000-01-14 |
| NO20000202L true NO20000202L (no) | 2000-02-10 |
Family
ID=26731289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000202A NO20000202L (no) | 1997-07-17 | 2000-01-14 | Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6451317B1 (ko) |
| EP (1) | EP1003549A4 (ko) |
| JP (1) | JP2001510169A (ko) |
| KR (1) | KR20010021953A (ko) |
| CN (1) | CN1272062A (ko) |
| AU (1) | AU748973B2 (ko) |
| BR (1) | BR9811475A (ko) |
| CA (1) | CA2297072A1 (ko) |
| NO (1) | NO20000202L (ko) |
| NZ (1) | NZ502437A (ko) |
| PL (1) | PL338146A1 (ko) |
| WO (1) | WO1999003501A1 (ko) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999061053A1 (en) * | 1998-05-29 | 1999-12-02 | Chiron Corporation | Combination meningitidis b/c vaccines |
| GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
| US20030215469A1 (en) * | 1998-11-02 | 2003-11-20 | Microbiological Research Authority | Multicomponent meningococcal vaccine |
| US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
| DK2270173T3 (en) | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisserial combination compositions |
| GB9928196D0 (en) * | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| DK1248647T3 (da) * | 2000-01-17 | 2010-09-27 | Novartis Vaccines & Diagnostic | Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner |
| US20020192205A1 (en) * | 2001-05-11 | 2002-12-19 | Francis Michon | Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci |
| MX339524B (es) * | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
| GB0213622D0 (en) * | 2002-06-13 | 2002-07-24 | Glaxosmithkline Biolog Sa | Vaccine Corporation |
| GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| GB0225736D0 (en) * | 2002-11-05 | 2002-12-11 | Adjuvantix Ltd | T-Cell Independent Vaccine |
| CA2514328C (en) * | 2003-01-30 | 2020-01-14 | Chiron Srl | Injectable vaccines against multiple meningococcal serogroups |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| GB0419627D0 (en) * | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| EP1928419A1 (en) | 2005-09-30 | 2008-06-11 | Lipoxen Technologies Limited | Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant |
| MX2010004910A (es) | 2007-11-08 | 2010-05-14 | Neogenix Oncology Inc | Anticuerpos monoclonales recombinantes y antigenos correspondientes para canceres colonico y pancreatico. |
| EP2383035A4 (en) | 2008-12-03 | 2017-11-22 | Kaneka Corporation | Formyl group-containing porous support, adsorbent using same, method for producing same, and method for producing the adsorbent |
| CA2772104A1 (en) * | 2009-08-27 | 2011-03-03 | Novartis Ag | Hybrid polypeptides including meningococcal fhbp sequences |
| AU2011300418B2 (en) | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| CN104602702B (zh) | 2012-09-18 | 2021-08-27 | 葛兰素史密丝克莱恩生物有限公司 | 外膜囊泡 |
| RU2662968C2 (ru) | 2013-09-08 | 2018-07-31 | Пфайзер Инк. | Иммуногенная композиция против neisseria meningitidis (варианты) |
| CN109790194B (zh) | 2016-11-23 | 2021-07-23 | 广州华睿光电材料有限公司 | 金属有机配合物、高聚物、组合物及有机电子器件 |
| WO2018144799A1 (en) | 2017-02-03 | 2018-08-09 | SCHADECK, Eva, Barbara | Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof |
| CN107966436B (zh) * | 2017-10-27 | 2020-10-02 | 中国农业大学 | 一种基于镉的功能核酸的可视化传感器及其应用 |
| CA3146023A1 (en) | 2019-07-05 | 2021-01-14 | Iomx Therapeutics Ag | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof |
| WO2022008027A1 (en) | 2020-07-06 | 2022-01-13 | Iomx Therapeutics Ag | Antibodies binding igv of igsf11 (vsig3) and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4695624A (en) * | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
| IT1187753B (it) * | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
| EP0338265B1 (en) * | 1988-04-19 | 1994-05-04 | American Cyanamid Company | Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine |
| US5439808A (en) | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
| US6153406A (en) * | 1993-07-23 | 2000-11-28 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B |
| US5747287A (en) | 1995-04-28 | 1998-05-05 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
| CZ327897A3 (cs) * | 1995-06-07 | 1998-02-18 | Alberta Research Council | Imunogenní a imunostimulační oligosacharidové kompozice, způsoby jejich přípravy a použití |
| HUP9901039A2 (hu) | 1996-02-01 | 1999-07-28 | North American Vaccine, Inc. | Neisseria meningitidis B-csoportba tartozó külső-membrán-fehérjéjének (MB3) expressziója élesztőben, továbbá vakcinák |
-
1998
- 1998-07-17 AU AU84946/98A patent/AU748973B2/en not_active Ceased
- 1998-07-17 US US09/118,180 patent/US6451317B1/en not_active Expired - Fee Related
- 1998-07-17 EP EP98935762A patent/EP1003549A4/en not_active Withdrawn
- 1998-07-17 PL PL98338146A patent/PL338146A1/xx unknown
- 1998-07-17 WO PCT/US1998/014838 patent/WO1999003501A1/en not_active Application Discontinuation
- 1998-07-17 CN CN98808847A patent/CN1272062A/zh active Pending
- 1998-07-17 KR KR1020007000518A patent/KR20010021953A/ko not_active Application Discontinuation
- 1998-07-17 NZ NZ502437A patent/NZ502437A/en unknown
- 1998-07-17 BR BR9811475-1A patent/BR9811475A/pt not_active IP Right Cessation
- 1998-07-17 JP JP2000502796A patent/JP2001510169A/ja not_active Withdrawn
- 1998-07-17 CA CA002297072A patent/CA2297072A1/en not_active Abandoned
-
2000
- 2000-01-14 NO NO20000202A patent/NO20000202L/no not_active Application Discontinuation
-
2002
- 2002-05-10 US US10/142,441 patent/US6613336B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU8494698A (en) | 1999-02-10 |
| US20020131984A1 (en) | 2002-09-19 |
| BR9811475A (pt) | 2000-08-15 |
| US6613336B2 (en) | 2003-09-02 |
| KR20010021953A (ko) | 2001-03-15 |
| AU748973B2 (en) | 2002-06-13 |
| NZ502437A (en) | 2001-11-30 |
| CN1272062A (zh) | 2000-11-01 |
| WO1999003501A9 (en) | 1999-04-22 |
| WO1999003501A1 (en) | 1999-01-28 |
| CA2297072A1 (en) | 1999-01-28 |
| EP1003549A1 (en) | 2000-05-31 |
| EP1003549A4 (en) | 2005-03-02 |
| PL338146A1 (en) | 2000-09-25 |
| JP2001510169A (ja) | 2001-07-31 |
| NO20000202D0 (no) | 2000-01-14 |
| US6451317B1 (en) | 2002-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000202L (no) | Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid | |
| HUP0103100A3 (en) | Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide | |
| DE69019164D1 (de) | Verbessertes meningokokkale polysaccharidkonjugatvakzin. | |
| BR9608199B1 (pt) | composição de vacina compreendendo um antìgeno, qs21 e um esterol. | |
| ZA200306176B (en) | Multivalent meningococcal polysaccharide-protein conjugate vaccine. | |
| ZA9811849B (en) | Vaccine. | |
| ZA988789B (en) | Vaccine. | |
| NO991815D0 (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
| FR2747802B1 (fr) | Microdispositif optomecanique, et application a un microdeflecteur optomecanique | |
| NO975513D0 (no) | 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel | |
| DE122005000046I1 (de) | Azellul{rer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enth{lt. | |
| ZA200201816B (en) | A vaccine composition and method of using the same. | |
| FI991275A (fi) | Menetelmä kattilassa, erityisesti soodakattilassa | |
| NL1003765A1 (nl) | Opvoedkundige inrichting. | |
| DK0811593T3 (da) | 1,4-diaryl-2-flour-2-buten som insektcider og acaricider | |
| IS4382A (is) | Ný peptíð með ónæmisbreytandi áhrif | |
| GB9611673D0 (en) | Meningococcal vaccine | |
| FR2715304B1 (fr) | Vaccin anti-allergique. | |
| DK1053224T3 (da) | Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel | |
| AU2001288236A1 (en) | Natural, non-allergenic, immune system stimulant | |
| GB9618890D0 (en) | An immunogenic determinant | |
| HUP0002359A3 (en) | Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide | |
| PL346645A1 (en) | IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE | |
| TR199800043A3 (tr) | Pim-tipi eszamanlama cihazi. | |
| DE69319144T2 (de) | Biegbares, aufblasbares kissen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |